Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.13 EUR
32.25 M EUR
572.93 M EUR
52.13 M
About Repligen Corporation
Sector
CEO
Olivier Dominique Loeillot
Headquarters
Waltham
Website
Founded
1981
FIGI
BBG000FSG8L3
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RGN is 139.55 EUR — it has increased by 0.18% in the past 24 hours. Watch REPLIGEN CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange REPLIGEN CORP stocks are traded under the ticker RGN.
RGN stock has fallen by −0.43% compared to the previous week, the month change is a 0.36% rise, over the last year REPLIGEN CORP has showed a −16.24% decrease.
We've gathered analysts' opinions on REPLIGEN CORP future price: according to them, RGN price has a max estimate of 216.33 EUR and a min estimate of 153.83 EUR. Watch RGN chart and read a more detailed REPLIGEN CORP stock forecast: see what analysts think of REPLIGEN CORP and suggest that you do with its stocks.
RGN stock is 0.72% volatile and has beta coefficient of 0.36. Track REPLIGEN CORP stock price on the chart and check out the list of the most volatile stocks — is REPLIGEN CORP there?
Today REPLIGEN CORP has the market capitalization of 7.82 B, it has decreased by −6.28% over the last week.
Yes, you can track REPLIGEN CORP financials in yearly and quarterly reports right on TradingView.
REPLIGEN CORP is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
RGN earnings for the last quarter are 0.39 EUR per share, whereas the estimation was 0.30 EUR resulting in a 28.22% surprise. The estimated earnings for the next quarter are 0.40 EUR per share. See more details about REPLIGEN CORP earnings.
REPLIGEN CORP revenue for the last quarter amounts to 135.41 M EUR, despite the estimated figure of 137.43 M EUR. In the next quarter, revenue is expected to reach 160.87 M EUR.
RGN net income for the last quarter is −587.38 K EUR, while the quarter before that showed 5.33 M EUR of net income which accounts for −111.01% change. Track more REPLIGEN CORP financial stats to get the full picture.
No, RGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 29, 2024, the company has 1.78 K employees. See our rating of the largest employees — is REPLIGEN CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REPLIGEN CORP EBITDA is 104.60 M EUR, and current EBITDA margin is 21.42%. See more stats in REPLIGEN CORP financial statements.
Like other stocks, RGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REPLIGEN CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REPLIGEN CORP technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REPLIGEN CORP stock shows the sell signal. See more of REPLIGEN CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.